Rob Royea
CEO & President, Histolix

Rob Royea

HistolixCEO & President


  • 30+ Years leading private and public medical diagnostic companies from start-up to $600M USD in annual sales with positive EBITDA gains.
  • Oversaw multiple successful FDA product filings for market commercialization.
  • Directed the National Accounts programs for Johnson and Johnson Medical and Acuson.
  • Pioneered the 1st analog-to-digital video conversion technology for cardiovascular ultrasound diagnosis, resulting in largest market-share globally for Acuson.
  • Initiated Acuson cardiology division from start-up to $200M in sales with eventual sale to Siemens Healthcare.
  • As North American Business Unit Leader oversaw marketing and operations for ultrasound, catheter, and picture archival divisions for Siemens Medical.
  • Founded a novel AI based breast cancer diagnostic company, Cyrcadia, Asia, Inc. which led to his recognition as one of the Top 40 Healthcare Transformers by MM&M Magazine in 2017.
  • As COO, successfully positioned Ziosoft, Inc., an AI based 3D/4D diagnostic technology company sale to Nantworks, Inc.
  • Assisted in the expansion of product assortment and eventual acquisition of Eklin Medical to VCA Antech in the Animal Healthcare arena.
  • Has been awarded multiple patents in the US and internationally in diagnostic technology and associated automated algorithm assessment.